EVIDENSE: Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Recruiting
CT.gov ID
NCT04676256
Collaborator
(none)
126
1
2
2
62.9

Study Details

Study Description

Brief Summary

The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late vitrectomy.

The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment occurring after a spontaneous vitreous hemorrhage.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Early vitrectomy
N/A

Detailed Description

The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late vitrectomy.

The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment occurring after a spontaneous vitreous hemorrhage.

Scientific background Spontaneous vitreous hemorrhage may occur after spontaneous posterior vitreous detachment and causes retinal break and retinal detachment in about 70% and 40% of cases respectively. The fundus examination and ultrasound have limited sensitivity to detect retinal breaks in these cases. Some retrospective studies have highlighted the benefit of an early vitrectomy for decreasing the rate of visual loss due to retinal detachment in these cases. However, to date, there is no national or international consensus regarding the management of spontaneous vitreous hemorrhage and the timing of vitrectomy.

Study design Prospective randomized clinical trial Primary objective To compare the results of an early vitrectomy versus ultrasound and fundus observation in spontaneous vitreous hemorrhage.

Secondary objectives To evaluate the rate of retinal complications in spontaneous vitreous hemorrhage treated either with early or delayed vitrectomy.

To evaluate the rate of visual loss in spontaneous vitreous hemorrhage treated either with early or delayed vitrectomy.

Primary criteria Rate of retinal detachment in eyes with spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month follow-up Secondary criteria Rate of retinal breaks and vitreo-retinal proliferation in eyes with spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month follow-up Visual acuity and rate of eyes with a loss of 5 letters or more among eyes with spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month follow-up Participants Patients with a spontaneous vitreous hemorrhage secondary to posterior vitreous detachment, with a reduced visibility of the fundus Inclusion criteria

  • Age > or = 18 years old

  • Spontaneous vitreous hemorrhage which is 1/ secondary to posterior vitreous detachment; 2/ acute: which duration is < 15 days, 3/ dense: reduced visibility of the fundus

Exclusion criteria:
  • Retinal detachment at the initial examination

  • Any history of vascular retinal disease (diabetic retinopathy, retinal vein occlusion…)

  • Any history of uveitis, age-related macular degeneration

  • History of a recent ocular traumatism (< 3 months)

  • History of a recent retinal laser treatment (< 3 months) or vitreo-retinal surgery (< 3 months)

  • Absence of consent Experimental group Eyes with spontaneous vitreous hemorrhage treated with early vitrectomy (n = 63) Active Comparator group Eyes with spontaneous vitreous hemorrhage only observed using fundus examination and B-ultrasound (n = 63) Study duration Inclusion: 12 months Participation: 6 months Total duration: 18 months

Study Design

Study Type:
Interventional
Anticipated Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparaison de la Vitrectomie précoce et de la Surveillance Simple Dans la Prise en Charge Des hémorragies du vitré spontanées EVIDENSE Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage
Actual Study Start Date :
Jul 2, 2021
Anticipated Primary Completion Date :
Sep 1, 2021
Anticipated Study Completion Date :
Sep 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early Vitrectomy

Experimental arm will be treated with early vitrectomy early vitrectomy 7 days after vitreous hemorrhage diagnosis

Procedure: Early vitrectomy
Eyes with spontaneous vitreous hemorrhage treated with early vitrectomy (n = 63)

Active Comparator: Comparator

Active comparator arm will have fundus and ultrasound observation. Late vitrectomy may be indicated after 3 months of follow-up if needed. Late vitrectomy will be performed in case of persistant vitreous hemorrhage after 3 months of folllow-up

Procedure: Early vitrectomy
Eyes with spontaneous vitreous hemorrhage treated with early vitrectomy (n = 63)

Outcome Measures

Primary Outcome Measures

  1. Rate of retinal detachment [6 months after intervention]

    number of eyes with a retinal detachment in each group. The presence of retinal detachment will be assessed on fundus examination

Secondary Outcome Measures

  1. Rate of retinal breaks [6 months after intervention]

    number of eyes with a retinal breaks in each group. The presence of retinal breaks will be assessed on fundus examination

  2. Rate vitreo-retinal proliferation [6 months after intervention]

    number of eyes with a vitreo-retinal proliferation in each group. The presence of vitreo-retinal proliferation will be assessed on fundus examination

  3. Visual acuity [6 months after intervention]

    visual acuity will be measured using Snellen and/or ETDRS chart

  4. Rate of eyes with a loss of 5 letters or more [6 months after intervention]

  5. Rate of cataract [6 months after intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > or = 18 years old

  • Spontaneous vitreous hemorrhage which is :

  1. secondary to posterior vitreous detachment;

  2. acute: which duration is < 15 days,

  3. dense: reduced visibility of the fundus

Exclusion Criteria:
  • Retinal detachment at the initial examination

  • Any history of vascular retinal disease (diabetic retinopathy, retinal vein occlusion…)

  • Any history of uveitis, age-related macular degeneration

  • History of a recent ocular traumatism (< 3 months)

  • History of a recent retinal laser treatment (< 3 months) or vitreo-retinal surgery (< 3 months)

  • Absence of oral and written consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Lariboisiere Paris Ile De France France 75010

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT04676256
Other Study ID Numbers:
  • P170408J
  • IDRCB
First Posted:
Dec 21, 2020
Last Update Posted:
Aug 30, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2021